|
61 |
The role and challenges of cluster randomised trials for global health |
Louis Dron, Monica Taljaard, Yin Bun Cheung, Rebecca Grais, Nathan Ford, Kristian Thorlund, Fyezah Jahan, Etheldreda Nakimuli-Mpungu, *Denis Xavier*, Zulfiqar A Bhutta, Jay JH Park, Edward J Mills |
The Lancet Global Health |
2021 |
|
62 |
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3study
|
Jackie Bosch, Eva M Lonn, Hyejung Jung, Jun Zhu, Lisheng Liu, Patricio Lopez-Jaramillo, *Prem Pais*, *Denis Xavier*, Rafael Diaz, Gilles Dagenais, Antonio Dans, Alvaro Avezum, Leopoldo S Piegas, Alexander Parkhomenko, Kati Keltai, Matyas Keltai, Karen Sliwa, Claus Held, Ronald J G Peters, Basil S Lewis, Petr Jansky, Khalid Yusoff, Kamlesh Khunti, William D T, Christopher M Reid, John Varigos, Philip Joseph, Lawrence A Leiter, Salim Yusuf
|
European Heart Journal |
2021 |
|
63 |
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial |
David Collister, Lawrence Mbuagbaw, Gordon Guyatt, PJ Devereaux, Karthik K, Tennankore, Gilmar Reis, Laura Sola, *Denis Xavier*, Vivekanand Jha, Martin Gallagher, Antonio L Dans, Wen Liu, Janak de Zoysa, Camilo Félix, Patrick B Mark, Zuo Li, Jessica Tyrwhitt, Joanne Wilkinson, Patrick Sheridan, Fei Yuan, Michael Walsh, ACHIEVE investigators
|
Contemporary Clinical Trials, 2021 |
2021 |
|
64 |
The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery |
Andre Lamy, Wesley Tong, Rajibul Mian, Jessica Vincent, Wojciech Szczeklik, Bruce M Biccard, Emmanuelle Duceppe, Maria Graza Franzosi, Sadeesh K Srinathan, Christian S Meyhoff, Joel Parlow, *Denis Xavier*, PJ Devereaux |
American Journal of Cardiovascular Drugs |
2021 |
|
65 |
The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990–2019 |
Gagandeep Singh, Meenakshi Sharma, G Anil Kumar, N Girish Rao, Kameshwar Prasad, Prashant Mathur, Jeyaraj D Pandian, Jaimie D Steinmetz, Atanu Biswas, Pramod K Pal, Sanjay Prakash, PN Sylaja, Emma Nichols, *Denis Xavier*, et al. |
The Lancet Global Health |
2021 |
|
66 |
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis |
Philip Joseph, Gholamreza Roshandel, Peggy Gao, *Prem Pais*, Eva Lonn, *Denis Xavier*, Alvaro Avezum, Jun Zhu, Lisheng Liu, Karen Sliwa, Habib Gamra, Shrikant I Bangdiwala, Koon Teo, Jackie Bosch, Gilles R Dagenais, Reza Malekzadeh, Salim Yusuf, Polypill Trialists’ Collaboration |
Lancet |
2021 |
|
67 |
Topical Controlled Warm Oxygen Therapy Delivered Through a Novel Device (KADAM™) to Treat Diabetic Foot Ulcers: A Randomized Controlled, Open, Pilot Trial |
Anirudh V, *Kamath DY*, Ghosh S, *Bhuvana KB*, Sharma S, Maruthy K, *Pais P*, *Xavier D* |
Indian Journal of Surgery |
2021 |
|
68 |
Anger or emotional upset and heavy physical exertion as triggers of stroke: the INTERSTROKE study |
Andrew Smyth, Martin O’Donnell, Graeme J Hankey, Sumathy Rangarajan, Patricio Lopez-Jaramillo, *Denis Xavier*, Hongye Zhang, Michelle Canavan, Albertino Damasceno, Peter Langhorne, Salim Yusuf |
European Heart Journal |
2021 |
|
69 |
The Cost Implications of a Polypill for Primary Prevention in the TIPS-3 Trial |
Andre Lamy, Wesley Tong, Philip Joseph, Peggy Gao, *Prem Pais*, Patricio Lopez-Jaramillo, Marjan Walli-Attaei, Tony Dans, *Denis Xavier*, Shamim Talukder, Anwar Santoso, Habib Gamra, Salim Yusuf, TIPS-3 Investigators |
European Heart Journal |
2021 |
|
70 |
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial |
Harpreet S Bajaj, Hertzel C Gerstein, Purnima Rao-Melacini, Jan Basile, Helen Colhoun, Ignacio Conget, William C Cushman, *Denis Xavier*, Gilles R Dagenais, Edward Franek, Markolf Hanefeld, Matyas Keltai, Mark Lakshmanan, Fernando Lanas, Lawrence A Leiter, Patricio Lopez-Jaramillo, Valdis Pirags, Nana Pogosova , Jeffrey Probstfield, Peter Raubenheimer, Lars Ryden, Jonathan E Shaw, Wayne H-H Sheu |
The Lancet Diabetes & Endocrinology |
2021 |
|
71 |
Antihypertensives and Statin Therapy for Primary Stroke Prevention |
Bosch J, Lonn EM, Dagenais GR, Gao P, Jaramillo PL, Zhu J, *Pais P*, Yusuf S ,for the HOPE-3 Investigators |
Stroke |
2021 |
|
72 |
Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial |
Bahit MC, Granger CB, Alexander JH, Mulder H, Wojdyla DM, Hanna M, Goto S, Xavier D, Verheugt FWA, Lanas F, Hijazi Z, Wallentin L, Lopes RD |
Int J Cardiol |
2020 |
|
73 |
One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac Surgery |
Sessler DI, Conen D, Leslie K, Yusuf S, Popova E, Graham M, Kurz A, Villar JC, Mrkobrada M, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Xavier D, Chan MTV, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Torres D, Wang CY, Paniagua P, Berwanger O, Srinathan S, Landoni G, Manach YL, Whitlock R, Lamy A, Balasubramanian K, Gilron I, Turan A, Pettit S, Devereaux PJ; Perioperative Ischemic Evaluation-2 Trial (POISE-2) Investigators. |
Anesthesiology |
2020 |
|
74 |
Patient and caregiver reported facilitators of self-care among patients with chronic heart failure: report from a formative qualitative study |
Kamath DY, Bhuvana KB, Dhiraj RS, Xavier D, Varghese K, Salazar LJ, Granger CB, Pais P, Granger BB |
Wellcome Open Res |
2020 |
|
75 |
Nocturnal hypertension and left ventricular hypertrophy in pediatric renal transplant recipients in South India |
Pais P, Dello Strologo L, Iyengar A, Velusamy V, Greenbaum LA |
Pediatr Transplant |
2020 |